C. Scoppetta, C. Casali, S. D'Agostini, F. Pauri, G. Amabile
{"title":"[Inflammatory myopathies].","authors":"C. Scoppetta, C. Casali, S. D'Agostini, F. Pauri, G. Amabile","doi":"10.32388/340890","DOIUrl":"https://doi.org/10.32388/340890","url":null,"abstract":"COMMON TREATMENTS SIGNS/ SYMPTOMS The most common sign of inflammatory myopathies is weakness in the large muscles of the shoulders, neck or hips. Inflammation damages tissue so you lose strength in these muscles. Inflammatory myopathies may cause problems like these: • Trouble climbing stairs, lifting objects over your head or getting out of a seat • Choking while eating or intake of food into the lungs • Shortness of breath • Cough Dermatomyositis causes skin rashes that look like red or purple spots on the eyelids, or scaly, red bumps on the elbows, knuckles or knees. Children may also have white spots on their skin called calcinosis or vasculitis, a blood vessel inflammation that causes skin lesions.","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"58 1 1","pages":"11-4"},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45743737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Sartucci, A. Pellegrinetti, L. Voci, L. Sagliocco, L. Bonfiglio, L. Murri
{"title":"Striated sphincter and genital dysfunctions in multiple sclerosis patients: an electrophysiological approach","authors":"F. Sartucci, A. Pellegrinetti, L. Voci, L. Sagliocco, L. Bonfiglio, L. Murri","doi":"10.1016/0013-4694(93)91245-V","DOIUrl":"https://doi.org/10.1016/0013-4694(93)91245-V","url":null,"abstract":"","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"7 1","pages":"85-89"},"PeriodicalIF":0.0,"publicationDate":"1993-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0013-4694(93)91245-V","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52862840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Nuti, C Maremmani, R Ceravolo, N Pavese, U Bonuccelli, A Muratorio
{"title":"[Dexamethasone therapy in Huntington chorea: preliminary results].","authors":"A Nuti, C Maremmani, R Ceravolo, N Pavese, U Bonuccelli, A Muratorio","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neuroleptic drugs represent the current therapy for Huntington's chorea (HC). However neuroleptics can improve involuntary movements, but not functional performance and disease progression. Several clinical and experimental data suggest the existence of functional relationship between corticosteroids and extrapyramidal system. We administered dexamethasone to six choreics, all female. Dexamethasone was given i.m. at dose of 4 mg/die for 20 days and 8 mg/die for 20 days more. Dexamethasone at both the doses used, determined significant improvement (p less than 0.05) of dyskinesia, evaluated by AIMS, and manual dexterity, evaluated by Tapping test. Although at present it is not clear which mechanism are responsible for this of dexamethasone favourable effect, it might open new perspectives in HC therapy.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"225-7"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13000938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F Baronti, S Ruggieri, M M Mouradian, A Bonamartini, P Bocciarelli, M F De Pandis, T N Chase, A Agnoli
{"title":"[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease].","authors":"F Baronti, S Ruggieri, M M Mouradian, A Bonamartini, P Bocciarelli, M F De Pandis, T N Chase, A Agnoli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Motor fluctuations often complicate chronic levodopa treatment of Parkinson's disease. Pharmacologically, these phenomena are characterized by a progressive shortening of the duration of action of levodopa and a gradual narrowing of the range of \"optimally effective\" doses, able to improve parkinsonian akinesia without inducing abnormal involuntary movements. The effects of a continuous intravenous infusion of levodopa lasting 9 +/- 0.3 days on these clinical-pharmacological indices have been studied in 12 parkinsonian patients. Continuous infusion therapy gradually ameliorated motor fluctuations by more than 40%, and this improvement lasted for at least 6 days after resuming standard oral therapy. Moreover, levodopa duration of action was prolonged by about 30%, and the range of \"optimally effective\" dose was widened by about 50%. The above data suggest the possibility of plastic modifications of the pathogenetic mechanisms underlying motor fluctuations in Parkinson's disease, and a potential deleterious effect of intermittent oral therapy. Consequently, continuous dopaminergic stimulation, when used in the early stages of the disease, might theoretically have a prophylactic role on the development or worsening of motor fluctuations.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"210-4"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12977258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Cerebrovascular manifestations while taking combined estrogens and progestins for contraceptive purposes. Clinical cases].","authors":"L Sinibaldi, C Gerace, A Meccia","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study concerns 20 patients with cerebrovascular disease in the course of oral contraception with estrogens/progestins. The assumption of oral contraceptives appears to be related to the cerebrovascular manifestations, which could be caused by alterations of the blood vessel walls or of the coagulative process induced by estrogens/progestins. The thrombogenic action of these substances could be enhanced by preexisting conditions such as protein C or protein S deficiency.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"242-5"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12975703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R Massetani, R Galli, R Calabrese, F Sartucci, P Rindi, L Severino Brandi, L Murri
{"title":"[Status epilepticus in chronically dialyzed patients treated with erythropoietin].","authors":"R Massetani, R Galli, R Calabrese, F Sartucci, P Rindi, L Severino Brandi, L Murri","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This paper describes the clinical features of two patients with chronic renal failure and uremic anaemia treated with recombinant human erythropoietin (9000 I.U. subcutaneously subdivided in 3 times weekly at the end of haemodialysis treatment) who developed seizures and status epilepticus. This treatment has unequivocal benefits but in some patients has been accompanied by elevated blood pressure leading to hypertensive encephalopathy with seizures. In fact, the correction of the anaemia results in a rise in packed cell volume with a consequent increase in blood viscosity, predisposing to increased vascular resistance and the development of hypertension.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"215-8"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12977259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P Piccini, P Del Dotto, C Pardini, P D'Antonio, G Rossi, U Bonuccelli
{"title":"[Diurnal worsening in Parkinson patients treated with levodopa].","authors":"P Piccini, P Del Dotto, C Pardini, P D'Antonio, G Rossi, U Bonuccelli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Parkinson's disease (PD) patients show a good response to levodopa in the morning, and reduced duration or complete failure of response later in the day, but the pathophysiology of this phenomenon remains unclear. We evaluated motor performance hourly over a twelve-hour period in patients treated with levodopa/carbidopa (group A), with bromocriptine (group B), and in \"de novo\" patients (group C). At 8 am, 12 and 4 pm, group A patients received standard doses of levodopa/carbidopa, whereas patients of group B and C took, respectively, 5 mg bromocriptine and placebo. In \"de novo\" patients and in patients under bromocriptine we did not observe significant diurnal changes in motor score, whereas in patients under levodopa a progressive daytime worsening, which significantly correlated with progressive increase in 3-O-methyldopa plasma levels, was visible. These data seem to indicate a contributory role of pharmacokinetic or pharmacodynamic factors related to levodopa assumption, rather than to the underlying disease, in the afternoon worsening in PD.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"219-24"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12977260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Antiphospholipid antibodies and cerebral ischemia].","authors":"S Severi, M Ghezzi, P Zolo, A Bianchi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lupus anticoagulants (LAs) and anticardiolipin antibodies (ACAs) are acquired circulating immunoglobulins that cross-react with anionic and neural phospholipids. These factors may display anticoagulant properties in vitro by interfering with phospholipid-dependent coagulation tests. These antibodies are usually not associated with a bleeding tendency. In fact, paradoxically to their name, since the initial recognition they have been related to systemic and cerebral thromboembolisms, despite their in vitro \"anticoagulant\" properties. We report the clinical and laboratory findings in 4 LAs and ACAs positive patients with brain ischemia.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"203-9"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12975154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C Paradiso, V Caruso, S Rossi, R Cioni, S Passero, F Giannini, R Ravenni, N Battistini
{"title":"[Maps of somatosensory evoked potentials from the arm in patients with neoplasms and post-traumatic brain lesions].","authors":"C Paradiso, V Caruso, S Rossi, R Cioni, S Passero, F Giannini, R Ravenni, N Battistini","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Short-latency somatosensory evoked potentials by the stimulation of the median nerve at the wrist, were recorded in six patients (four with cerebral tumors and two with post-trauma lesions). The electrodes were placed on the scalp following the 10-20 International System. A reference electrode was placed on earlobe contralateral to the site of the stimulation. Eleven normal subjects were used as control (mean age 64.4 +/- 12.05). We used the Brain-Surveyor-Basis Trade system which allowed us to elaborate the results by coloured mapping through linear interpolation of signal amplitudes. The following parameters were investigated: peak latencies of the N13, N20, P22, N30 waves; amplitudes of the post-rolandic P14-N20, N20-P25, pre-rolandic P22-N30 components and the central conduction time N13-N20 (CCT). The evaluation of latencies was not significant in determining the lesion site. On the contrary, the evaluation of amplitudes revealed expressive asymmetry, though it did not define the nature of alteration (increase or decrease due to lesion), and the correlation between these variations and the site of the lesion. The authors discussed the possibility that amplitude abnormalities in patients with tumors were related either to the tumors and/or drug effects.</p>","PeriodicalId":76494,"journal":{"name":"Rivista di neurologia","volume":"61 6","pages":"228-32"},"PeriodicalIF":0.0,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12977262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}